Merrill Lynch, Goldman Sachs, Citigroup, Credit Suisse, and Nomura all say American lithium hydroxide leader Livent Corp is a BUY, creating stark contrast between themselves and Morgan Stanley

Posted by on November 5, 2018 9:18 pm
Categories: Lithium

Share this Content


As reported by Motley Fool, Merrill Lynch, Goldman Sachs, Citigroup, Credit Suisse, and Nomura all say American lithium hydroxide leader Livent Corp is a BUY, creating stark contrast between themselves and Morgan Stanley.

For more details, click here to read Motley Fool’s full article.


If you enjoyed this article, be sure to check our homepage at NewEnergyNarrative.com and my Twitter and Facebook pages for more help with your due diligence and stock/company research!

I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from/through New Energy Narrative, which I am the founder and owner of).

More Recent Posts


Share this Content

Leave a Reply